Skip to content

Insider · CIK 0001881430

Christopher DelOrefice

cfoofficerdirector

Files at BDX (BECTON DICKINSON & CO), RMD (RESMED INC). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 26, 2024BDX
BECTON DICKINSON & CO
AGrant or award
Common Stock
+4,884$0.00$017,676Nov 29, 2024
Nov 26, 2024BDX
BECTON DICKINSON & CO
AGrant or award
Common Stock
+9,015$0.00$026,691Nov 29, 2024
Nov 26, 2024BDX
BECTON DICKINSON & CO
FTax withholding
Common Stock
-5,192$0.00$021,499Nov 29, 2024
Nov 26, 2024BDX
BECTON DICKINSON & CO
AGrant or award
Stock Appreciation Rightsderivative
+19,138$0.00$019,138Nov 29, 2024
Nov 20, 2024RMD
RESMED INC
AGrant or award
ResMed Common Stock
+1,083$0.00$01,350Nov 22, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Christopher DelOrefice: insider trades and track record | InsiderTell